These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31570461)

  • 41. Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C.
    Tokushige K; Hashimoto E; Yatsuji S; Tobari M; Taniai M; Torii N; Shiratori K
    J Gastroenterol; 2010 Sep; 45(9):960-7. PubMed ID: 20376504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.
    Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.
    Hernandez-Alejandro R; Croome KP; Drage M; Sela N; Parfitt J; Chandok N; Marotta P; Dale C; Wall W; Quan D
    World J Gastroenterol; 2012 Aug; 18(31):4145-9. PubMed ID: 22919246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes mellitus increases the risk of intrahepatic recurrence of hepatocellular carcinoma after surgical resection.
    Choi Y; Choi Y; Choi CS; Lee YH
    Tumori; 2017 May; 103(3):279-285. PubMed ID: 28085178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of anatomical liver sectionectomy for patients with a solitary hepatocellular carcinoma from 2 to 5 cm in greatest diameter.
    Yamamoto M; Ariizumi S; Katagiri S; Kotera Y; Takahashi Y
    J Surg Oncol; 2009 Dec; 100(7):585-8. PubMed ID: 19653247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.
    Yang SL; Liu LP; Sun YF; Yang XR; Fan J; Ren JW; Chen GG; Lai PB
    J Gastroenterol; 2016 Jul; 51(7):722-32. PubMed ID: 26607653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients.
    Harada N; Shirabe K; Maeda T; Kayashima H; Ishida T; Maehara Y
    World J Surg; 2015 Apr; 39(4):1044-51. PubMed ID: 25446481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.
    Sasaki K; Shindoh J; Margonis GA; Nishioka Y; Andreatos N; Sekine A; Hashimoto M; Pawlik TM
    JAMA Surg; 2017 Mar; 152(3):e165059. PubMed ID: 28052155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome.
    Cauchy F; Zalinski S; Dokmak S; Fuks D; Farges O; Castera L; Paradis V; Belghiti J
    Br J Surg; 2013 Jan; 100(1):113-21. PubMed ID: 23147992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
    Minagawa M; Makuuchi M; Takayama T; Kokudo N
    Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma.
    Liau KH; Ruo L; Shia J; Padela A; Gonen M; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; DeMatteo RP
    Cancer; 2005 Nov; 104(9):1948-55. PubMed ID: 16196045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic impact of concurrent nonalcoholic fatty liver disease in patients with chronic hepatitis B-related hepatocellular carcinoma.
    Yoon JS; Lee HY; Chung SW; Kim SW; Chang Y; Lee YB; Cho EJ; Lee JH; Yu SJ; Kim H; Yoon JH; Kim YJ
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1960-1968. PubMed ID: 32128882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired phosphate and tension homologue deleted on chromosome 10 expression and its prognostic role in radical surgery for hepatocellular carcinoma with family aggregation resulting from hepatitis B and liver cirrhosis.
    Zhong Y; Yan J; Deng M; Hu K; Yao Z; Zou Y; Xu R
    Exp Biol Med (Maywood); 2013 Aug; 238(8):866-73. PubMed ID: 23828588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease.
    Wakai T; Shirai Y; Sakata J; Korita PV; Ajioka Y; Hatakeyama K
    J Gastrointest Surg; 2011 Aug; 15(8):1450-8. PubMed ID: 21512848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver.
    Faber W; Sharafi S; Stockmann M; Denecke T; Sinn B; Puhl G; Bahra M; Malinowski MB; Neuhaus P; Seehofer D
    Surgery; 2013 Apr; 153(4):510-7. PubMed ID: 23122930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.